Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|September 12, 2014
Prognostic value of human papillomavirus in anal squamous cell carcinomaPaola Simona Ravenda, Elena Magni, Edoardo Botteri, et al.
Arthritis and Rheumatism|October 5, 2011
Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosusTania Colasanti, Angela Maselli, Fabrizio Conti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 28, 2012
T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagyCristiano Alessandri, Cristiana Barbati, Davide Vacirca, et al.
Cancers|February 25, 2023
The Genetic and Immunologic Landscape Underlying the Risk of Malignant Progression in Laryngeal DysplasiaFrancesco Chu, Fausto Maffini, Daniela Lepanto, et al.
Cancers|April 12, 2022
Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive PatientsCaterina Fumagalli, Ilaria Betella, Alessandra Rappa, et al.
Critical Reviews in Oncology/Hematology|June 25, 2024
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancerElena Guerini-Rocco, Konstantinos Venetis, Giulia Cursano, et al.
Histopathology|January 11, 2017
Recurrent NAB2-STAT6 gene fusions and oestrogen receptor-α expression in pulmonary adenofibromasNicola Fusco, Elena Guerini-Rocco, Claudia Augello, et al.
Journal of Autoimmunity|January 28, 2015
Autoantibodies specific to D4GDI modulate Rho GTPase mediated cytoskeleton remodeling and induce autophagy in T lymphocytesCristiana Barbati, Cristiano Alessandri, Marta Vomero, et al.
Clinical Lung Cancer|October 31, 2025
Actionable Gene Alterations in Resected Non-Small Cell Lung Cancer: Primary Results From the AGA-R StudyIlaria Attili, Gloria Pellizzari, Luca Bertolaccini, et al.
Pharmacogenomics|March 5, 2024
<i>PIK3CA</i> testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratoriesFrancesco Pepe, Konstantinos Venetis, Giulia Cursano, et al.
Pageof 5